Trademark: DUVENSYS 2330435
Word
DUVENSYS
ID
2330435
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
27 January 2023
Registration Date
27 January 2023
Renewal Date
27 January 2033
Owner(s)
Service
WRAYS PTY LTD
Goods and Services:
Class 5:
Contraceptive preparations; contraceptive sponges; chemical contraceptives; oral contraceptives; Pharmaceutical preparations and substances for use in relation to women's health; Pharmaceutical preparations and substances containing hormones; Pharmaceutical preparations and substances containing progesterone; Pharmaceutical preparations and substances in the nature of hormone replacement therapy [HRT]; pharmaceutical preparations and substances for use in relation to reproductive health; pharmaceutical preparations and substances for use in relation to contraception; pharmaceutical preparations and substances for use in relation to conception; pharmaceutical preparations and substances for use in relation to fertility; fertility enhancement preparations; pharmaceutical preparations and substances for use in relation to the treatment of infertility; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for use in gynaecology; pharmaceutical preparations and substances for use in rheumatology; Pharmaceutical preparations for the treatment of menopause; Pharmaceutical preparations and substances for the alleviation of menopause-related symptoms; Pharmaceutical preparations and substances for the treatment of osteoperosis; Pharmaceutical preparations and substances for the alleviation of osteoperosis-related symptoms; Pharmaceutical preparations and substances for the treatment of bone disorders; Pharmaceutical preparations and substances for the treatment of bone loss; Pharmaceutical preparations and substances for the treatment of arthritis; Pharmaceutical preparations and substances for the treatment of calcium deficiency.
Contraceptive preparations; contraceptive sponges; chemical contraceptives; oral contraceptives; Pharmaceutical preparations and substances for use in relation to women's health; Pharmaceutical preparations and substances containing hormones; Pharmaceutical preparations and substances containing progesterone; Pharmaceutical preparations and substances in the nature of hormone replacement therapy [HRT]; pharmaceutical preparations and substances for use in relation to reproductive health; pharmaceutical preparations and substances for use in relation to contraception; pharmaceutical preparations and substances for use in relation to conception; pharmaceutical preparations and substances for use in relation to fertility; fertility enhancement preparations; pharmaceutical preparations and substances for use in relation to the treatment of infertility; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for use in gynaecology; pharmaceutical preparations and substances for use in rheumatology; Pharmaceutical preparations for the treatment of menopause; Pharmaceutical preparations and substances for the alleviation of menopause-related symptoms; Pharmaceutical preparations and substances for the treatment of osteoperosis; Pharmaceutical preparations and substances for the alleviation of osteoperosis-related symptoms; Pharmaceutical preparations and substances for the treatment of bone disorders; Pharmaceutical preparations and substances for the treatment of bone loss; Pharmaceutical preparations and substances for the treatment of arthritis; Pharmaceutical preparations and substances for the treatment of calcium deficiency.